Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 3/20 | 0.74 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.54 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.54 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.51 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18088401 | 0.83 | P2RX7 (0.75) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL18085886 | 0.80 | HDAC6 (0.56) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL25793264 | 0.79 | P2RX7 (0.46) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL18085908 | 0.79 | HDAC6 (0.60) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL22951079 | 0.78 | P2RX7 (0.68) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL22084931 | 0.76 | HDAC6 (0.61) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL18085902 | 0.75 | HDAC6 (0.63) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL20535265 | 0.74 | HDAC6 (1.00) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL20535891 | 0.74 | HDAC6 (0.73) | P2RX7HDAC6HDAC4HDAC5HDAC8 | |
| SCHEMBL19682901 | 0.73 | HDAC6 (0.72) | P2RX7HDAC6HDAC4HDAC5HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210030899-A1 | IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY | THE GENERAL HOSPITAL CORPORATION | 2021-02-04 | — | — | US | disclosed |
| US-10842891-B2 | Imaging histone deacetylases with a radiotracer using positron emission tomography | THE GENERAL HOSPITAL CORPORATION (US) | 2020-11-24 | — | — | US | disclosed |
| US-20160271276-A1 | IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY | THE GENERAL HOSPITAL CORPORATION | 2016-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210030899-A1 | IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY | HDAC1, HDAC11, HDAC3 | P2RX7 4700/4885HDAC6 13/4885HDAC4 8/4885 |
| US-20160271276-A1 | IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY | HDAC1, HDAC11, HDAC3 | P2RX7 4700/4885HDAC6 13/4885HDAC4 8/4885 |
| US-10842891-B2 | Imaging histone deacetylases with a radiotracer using positron emission tomography | HDAC1, HDAC11, HDAC3 | P2RX7 4700/4885HDAC6 13/4885HDAC4 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.